Kar Biswajit, Nascimbene Angelo, Loyalka Pranav, Kikec Jan, Nathan Sriram, Gregoric Igor D, Frazier O H
Departments of Cardiology (Drs. Kar, Kikec, Loyalka, Nascimbene, and Nathan) and Cardiovascular Surgery (Drs. Frazier and Gregoric), Texas Heart Institute, Houston, Texas 77030.
Tex Heart Inst J. 2013;40(4):445-8.
Left ventricular assist devices and percutaneous valve interventions have radically changed the treatment of advanced heart disease and minimized surgical morbidity in patients with end-stage heart failure who would not survive conventional surgery. We describe a successful approach to the simultaneous placement of a percutaneous left ventricular assist device and mitral valvuloplasty in a decompensated patient with end-stage ischemic cardiomyopathy, severe peripheral arterial disease, porcelain aorta, and severe mitral and aortic disease.
左心室辅助装置和经皮瓣膜介入治疗已彻底改变了晚期心脏病的治疗方式，并将那些无法在传统手术中存活的终末期心力衰竭患者的手术发病率降至最低。我们描述了一种成功的方法，即在一名患有终末期缺血性心肌病、严重外周动脉疾病、瓷化主动脉以及严重二尖瓣和主动脉疾病且病情失代偿的患者中，同时植入经皮左心室辅助装置和进行二尖瓣成形术。
